Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Neuway Pharma GmbH

NEUWAY Pharma GmbH, Bonn, Germany, is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications. NEUWAY had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH, Bonn, Germany, where it had been incubated for the last 4 years and supported with approx. € 2.3 million in research funding by the Federal Ministry of Education and Research. The company closed a series A financing round in May 2014 with a volume of € 2.7 million provided by a syndicate led by Wellington Partners. *

 

Period Start 2014-04-09 splitoff
  Predecessor Life Science Inkubator GmbH (LSI)
Products Industry CNS drug (neurological drug)
  Industry 2 drug delivery technology (drug formulation technology)
Persons Person Ernst, Oliver (Neuway Pharma 202210 CEO + Managing Director)
  Person 2 Scherhag, Rudi (Neuway Pharma 201508– Managing Director before ImClone Systems + Heidelberg Pharma + Roche Mannheim)
     
Region Region Bonn
  Country Germany
  Street 2 Ludwig-Erhard-Allee
c/o Life Science Inkubator GmbH
  City 53175 Bonn
    Address record changed: 2022-09-18
     
Basic data Employees B: 11 to 50 (2018-02-01)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-12-30

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Neuway Pharma GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top